VISIONABLE LTD

Comprehensive Financial Health Assessment: VISIONABLE LTD

1. Financial Health Score: D+

Explanation: Visionable Ltd is exhibiting symptoms of a classic "growth-stage hemorrhage." While the business has a strong gross margin and has successfully reduced its operating losses, it is currently surviving on life support via shareholder loans and equity injections. The balance sheet shows negative equity (technical insolvency), cash reserves at the parent company level are dangerously low, and the business carries a high burden of debt. The recent post-year-end funding and contract renewal provide a vital lifeline, but the patient remains in a fragile condition until revenue scales to match overheads.

2. Key Vital Signs

• Pulse (Revenue): £819,422 The patient's pulse is steady but exceptionally weak for a business of this scale and overhead structure. Revenue remained broadly flat year-over-year (£816k to £819k), indicating that the top-line growth has stalled, which is concerning for a software-as-a-service (SaaS) business that requires exponential growth to cover its fixed costs.

• Blood Pressure (Operating Loss): (£2.95 million) High blood pressure is putting immense strain on the system. Although the operating loss has improved significantly from the prior year (£4.47 million loss), the business is still burning through cash operationally. Admin expenses (£3.65 million) vastly exceed gross profit (£698k), meaning the company is bleeding cash just to keep the lights on.

• Cholesterol (Long-Term Liabilities): £7.2 million The company is carrying a heavy debt burden, primarily in the form of convertible loan notes. High interest expenses (£943k) are clogging the arteries, consuming a massive portion of the gross profit and severely restricting healthy cash flow.

• Blood Sugar (Cash Reserves): £112k Parent / £639k Group Cash levels are critically low, particularly at the parent company level. With a monthly operational burn rate likely in the hundreds of thousands, £112k represents a severe risk of hypoglycemia—a sudden cash crash that could prove fatal without immediate intervention.

• Anemia (Shareholders' Equity): (£1.75 million) The balance sheet is suffering from severe anemia. Accumulated losses have pushed shareholders' funds into negative territory. On paper, the company is technically insolvent, meaning its liabilities exceed its assets. It is only surviving because creditors (specifically convertible loan holders) have not demanded repayment.

• Miracle Supplement (Tax Credit): £5.14 million It is crucial to note that the reported "Profit for the year" of £1.27 million is a distortion of the underlying business health. The company actually made a pre-tax loss of £3.87 million, but a massive £5.14 million deferred tax credit was applied. This is a non-cash accounting adjustment, not a sudden influx of healthy operational revenue.

3. Diagnosis

Diagnosis: Chronic Cash Burn with Stabilizing Intervention

Visionable Ltd is suffering from a severe cash burn condition, a common ailment in the SaaS sector where upfront investment is required to build market share. The underlying business health is currently poor: the company does not generate enough revenue to cover its administrative overheads, and it is heavily reliant on high-interest convertible debt to fund operations. The interest on this debt is effectively consuming its gross profit.

However, there are clear signs that the treatment plan is starting to work. The surgical reduction in overheads reduced the operating loss by over £1.5 million compared to the previous year. Furthermore, the gross margin is an exceptionally healthy 85%, meaning that every new pound of revenue drops straight to the bottom line once the business reaches breakeven.

The most critical diagnostic indicator is actually found outside the reporting period. The post-year-end "blood transfusion" of £2.5m in equity funding and the renewal/expansion of the largest customer contract by 70% are the treatments keeping this patient alive. Without these, the prognosis would be terminal.

4. Recommendations

To restore full financial wellness, the following immediate and long-term treatments are prescribed:

1. Emergency Cash Management: With only £112k at the parent company level, cash flow requires daily monitoring. The recently injected £2.5m must be strictly ring-fenced for operational growth, not servicing old debt structures.
2. Debt Restructuring Surgery: The £7.2m in convertible loan notes and the associated £943k interest charge are suffocating the business. Negotiate with lenders to convert this debt to equity, or at the very least, defer interest payments to allow cash to remain in the business for growth.
3. Revenue Resuscitation: Leverage the 70% contract expansion from the largest customer immediately. The 85% gross margin means that scaling revenue will directly improve the operating loss. The primary focus must be aggressive, targeted sales to close the gap between current revenue and the £3.6m administrative cost base.
4. Cost Control Maintenance: Continue the strict diet of overhead reduction that was successfully implemented in 2024. Do not let administrative costs creep back up until the business has firmly achieved cash-flow breakeven.